The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $79.70

Today's change+0.10 +0.13%
Updated September 28 3:24 PM EDT. Delayed by at least 15 minutes.
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $79.70

Today's change+0.10 +0.13%
Updated September 28 3:24 PM EDT. Delayed by at least 15 minutes.

St. Jude Medical Inc Hits New 20-day High

St. Jude Medical Inc is up today by (U.S.)$0.10 or 0.13% to (U.S.)$79.70 and setting a new 20-day high. Over the last five days, shares have gained 0.33% and 29.03% year to date. Shares have outperformed the S&P 500 by 11.73% during the last year.

Key company metrics

  • Open(U.S.) $79.64
  • Previous close(U.S.) $79.60
  • High(U.S.) $79.87
  • Low(U.S.) $79.35
  • Bid / Ask(U.S.) $79.69 / (U.S.) $79.70
  • YTD % change+29.03%
  • Volume884,030
  • Average volume (10-day)2,002,470
  • Average volume (1-month)4,256,657
  • Average volume (3-month)3,015,639
  • 52-week range(U.S.) $48.83 to (U.S.) $84.00
  • Beta1.16
  • Trailing P/E34.61×
  • P/E 1 year forward19.70×
  • Forward PEG1.73×
  • Indicated annual dividend(U.S.) $1.24
  • Dividend yield1.56%
  • Trailing EPS(U.S.) $2.30
Updated September 28 3:24 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.09%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 02, 201607/02/2016Apr 02, 201604/02/2016Jan 02, 201601/02/2016Oct 03, 201510/03/2015
Revenue1,5621,4481,4471,339
Total other revenue--------
Total revenue1,5621,4481,4471,339
Gross profit1,066961946914
Total cost of revenue496487501425
Total operating expense1,2491,2201,3501,045
Selling / general / administrative502491588413
Research & development192188177161
Depreciation / amortization46464523
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1383923
Operating income31322897294
Interest income (expense), net non-operating-40-40-40-22
Gain (loss) on sale of assets--------
Other--------
Income before tax27013665261
Income after tax23895113215
Income tax, total3241-4846
Net income23895113215
Total adjustments to net income--------
Net income before extra. items23895113215
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23895113215
Inc. avail. to common incl. extra. items23895113215
Diluted net income23895113215
Dilution adjustment0--00
Diluted weighted average shares288286286286
Diluted EPS excluding extraordinary itemsvalue per share0.830.330.390.75
Dividends per sharevalue per share0.310.310.290.29
Diluted normalized EPSvalue per share0.930.550.390.75